TGOD received its oils production licence a year ago and then installed a state-of-the-art “supercritical CO2 extraction system”, capable of processing ultra-pure, environmentally friendly, organic cannabis oils.
TGOD is a premium global organic cannabis company, focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market.
Looking for skunk weed?
If TGOD sold whiskey – it would be 21-year-old Glenfiddich.
If TGOD sold hands bags – it would be GG Marmont Gucci.
If TGOD sold cars – it would be Continental GT Bentley.
TGOD’s specialty is “high quality, organic cannabis with sustainable, all-natural principles”.
TGOD has a planned production capacity of 219,000 kgs, while building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.
“Growing organic requires patience,” stated Csaba Reider, President of TGOD, “We know that our cannabis was worth the wait.”
While other LPs have been harvesting and selling cannabis, TGOD has quietly built a network of organic production facilities.
During pre-production, the big-money boys have continued to invest heavily in TGOD:
- May 2018 IPO raised gross proceeds of $132.3 million.
- Completed two bought deals worth $101.2 million.
- Completed private placements worth $77.6 million.
- Warrants exercised worth $63.4 million.
Fully funded for its domestic and international strategies; TGOD has no plans to return to the market for additional capital.
“In a recent study conducted by Hill & Knowlton,” states TGOD, “over 50% of recreational consumers stated it was important that their cannabis was organic. When the same question was posed to medical patients, that number increased to 63%.”
The Supercritical CO2 Extraction System process is free of toxic solvents and produces and “aromatic golden-brown oil that is as close to the original plant composition as can be achieved.”
TGOD’s oil extraction facility was built to GMP (Good Manufacturing Practices) specifications, and work is currently underway for European Union GMP certification, which will allow TGOD to expand distribution into global markets.
“We are pleased to offer TGOD’s medical patients access to new premium certified organic cannabis oils,” stated Brian Athaide, TGOD CEO. “This step will assist TGOD in transforming our premium quality organic raw material into a variety of higher-margin cannabis products.
Athaide is referring to “Cannabis 2.0” which will include beverages and edibles – pending regulatory approval.
TGOD’s oils feature terpene profiles to realize “entourage effects”.
The “entourage effect” is not the tendency to act like an asshole when you are in public with a group of friends.
The concept – introduced in 1998 by an Israeli doctor – is a mechanism by which non-psychoactive cannabis compounds modulate the overall psychoactive effects of the plant.
TGOD’s oil-production process is easily customizable to create full-spectrum strain-specific oils, as well as oils of varying cannabinoid and terpene concentrations.
A month ago, TGOD announced that sales of certified-organic cannabis have begun.
TGOD has received organic certification from Pro-cert Organic Systems and ECOCERT – a certification body that verifies production standards through surprise audits, and product analysis.
Aurora Cannabis (ACB.T) has invested approximately $78 million in TGOD for a 20% off-take agreement on Canadian production.
“Oil is predominantly a medical product, and patients want clean, organic efficacy with safe and easy delivery,” stated Dr. Rav Kumar, Chief Science Officer of TGOD. “Through our certified organic product and process we know we are providing patients the best possible experience.”
Full Disclosure: TGOD is an Equity Guru marketing client, and we own the stock.